Aarti Drugs considers formulations driven plant acqusition
![Aarti Drugs considers formulations driven plant acqusition](/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_small/1/5/8/9/2989851-1-eng-GB/Aarti-Drugs-considers-formulations-driven-plant-acqusition.jpg)
The Mumbai-based drugmaker told the BSE about the potential takeover earlier today. The firm explained that it “has considered a proposal to acquire an undertaking/Company at Baddi in Himachal Pradesh to cater its existing business of Toll [contract] manufacturing of formulations as an initiative to have its own facilities for this business subject to necessary diligences and approval processes.”
Aarti operates two production facilities - in Tarapur, Maharashtra and Sarigam, Gujarat – at which it produces more than 50 bulk active pharmaceutical ingredients (API), several pharmaceutical intermediates and a range of speciality chemicals.
Details of the potential acquisition target were not provided.